Literature DB >> 23785101

Effect of intraocular pressure on the Bayesian estimation of rates of visual field progression in glaucoma.

Felipe A Medeiros.   

Abstract

Entities:  

Mesh：

Year:  2013        PMID： 23785101      PMCID： PMC4597431          DOI： 10.1167/iovs.13-12348

Source DB:  PubMed          Journal:  Invest Ophthalmol Vis Sci        ISSN： 0146-0404            Impact factor:   4.799


× No keyword cloud information.
  6 in total

1.  The Advanced Glaucoma Intervention Study (AGIS): 7. The relationship between control of intraocular pressure and visual field deterioration.The AGIS Investigators.

Authors: 
Journal:  Am J Ophthalmol       Date:  2000-10       Impact factor: 5.258

2.  Improved prediction of rates of visual field loss in glaucoma using empirical Bayes estimates of slopes of change.

Authors:  Felipe A Medeiros; Linda M Zangwill; Robert N Weinreb
Journal:  J Glaucoma       Date:  2012-03       Impact factor: 2.503

3.  How useful is population data for informing visual field progression rate estimation?

Authors:  Andrew J Anderson; Chris A Johnson
Journal:  Invest Ophthalmol Vis Sci       Date:  2013-03-01       Impact factor: 4.799

4.  Incorporating risk factors to improve the assessment of rates of glaucomatous progression.

Authors:  Felipe A Medeiros; Linda M Zangwill; Kaweh Mansouri; Renato Lisboa; Ali Tafreshi; Robert N Weinreb
Journal:  Invest Ophthalmol Vis Sci       Date:  2012-04-24       Impact factor: 4.799

5.  Canadian Glaucoma Study: 3. Impact of risk factors and intraocular pressure reduction on the rates of visual field change.

Authors:  Balwantray C Chauhan; Frederick S Mikelberg; Paul H Artes; A Gordon Balazsi; Raymond P LeBlanc; Mark R Lesk; Marcelo T Nicolela; Graham E Trope
Journal:  Arch Ophthalmol       Date:  2010-08-09

6.  Reduction of intraocular pressure and glaucoma progression: results from the Early Manifest Glaucoma Trial.

Authors:  Anders Heijl; M Cristina Leske; Bo Bengtsson; Leslie Hyman; Boel Bengtsson; Mohamed Hussein
Journal:  Arch Ophthalmol       Date:  2002-10
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.